Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Post by RealScientiston Mar 07, 2016 3:20pm
205 Views
Post# 24631380

I see this release as a positive.

I see this release as a positive. It's funny how people can get so pissy so quickly when they see the stock price going down. Yes, we are all upset that we won't be getting financials until April, but I believe there is a reason for it. People will say that it's the auditors that are the problem, the CFO stepping down, etc. But I actually think this bodes much better for the stock price if it comes out in April. Why? You'll see the Q1 financials come out shortly after. If we were to get year end financials in February, and Q1 financials in late April or May, it would be hard to build momentum. The company wants those 50 cent warrants exercised. And if they released year end financials in February, the stock price would go up but would be brought back down quite easily when it was nearing the 10 day threshold before forcing them to be exercised. What we can expect to see now is year end financials coming out near the end of April and Q1 financials coming shortly after. The momentum this will bring will most likely ensure that all the warrants are exercised. It will be hard to stop the flying train when we see $500k in Q4 and (hopefully) over $1m in Q1. Just my opinion and I sure hope I'm right. Until then, I'll be buying more shares in the 30s if they become available. GLTA.
Bullboard Posts